Phase II-trial of concomitant hyperfractionated-accelerated radiotherapy (HART) with cisplatin (Cis) plus cetuximab (Cet) for locoregionally advanced inoperable squamous cell head and neck cancer: 5-year end results
Thomas Kuhnt(Leipzig University), Juergen Dunst(Martin Luther University Halle-Wittenberg), Rita Engenhart-Cabilic(Philipps University of Marburg), Michael Richter(Technical University of Munich), Peter Hass, Frank Sieker(Martin Luther University Halle-Wittenberg), A. Pirnasch(University of Rostock), Matthias Hautmann, Andreas Schreiber(University of South Australia), Kathrin Dellas(Martin Luther University Halle-Wittenberg)
Cited by 0
Related Papers
Randomized Phase II Trial of Chemoradiotherapy Plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer: CAO/ARO/AIO-12
|Journal of Clinical Oncology|2019|550
Chemoradiotherapy Plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for Patients With Locally Advanced Rectal Cancer
|JAMA Oncology|2021|369
Single-cell genomics reveals the lifestyle of <i>Poribacteria</i> , a candidate phylum symbiotically associated with marine sponges
|The ISME Journal|2010|278
Severe anemia is associated with poor tumor oxygenation in head and neck squamous cell carcinomas
|International Journal of Radiation Oncology*Biology*Physics|2000|218